ATXN2 Chromosome 12
Ataxin 2
Upload your DNA to see your personal genotypes for variants in ATXN2.
What This Gene Does
This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Associated Conditions (8)
ATXN2-related disorder
GM3 synthase deficiency
Inborn genetic diseases
Tip-toe gait
Amyotrophic lateral sclerosis
Spinocerebellar ataxia type 2
Parkinson disease
late-onset
Key Variants
RS140262591
Conflicting classifications of pathogenicity
ATXN2-related disorder, ATXN2-related disorder
Health Risk
RS746918429
Conflicting classifications of pathogenicity
Health Risk
RS778119853
Conflicting classifications of pathogenicity
GM3 synthase deficiency, GM3 synthase deficiency
Health Risk
RS948625674
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS975981325
Conflicting classifications of pathogenicity
Inborn genetic diseases, ATXN2-related disorder, Inborn genetic diseases
Health Risk
RS774827848
Likely pathogenic, low penetrance
Tip-toe gait, Tip-toe gait
Health Risk
RS193922927
Pathogenic
Amyotrophic lateral sclerosis, Spinocerebellar ataxia type 2, Spinocerebellar ataxia type 2
Health Risk
RS1885090126
Pathogenic; risk factor
Spinocerebellar ataxia type 2, Parkinson disease, late-onset
Health Risk
All Variants (8)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS140262591 | Health Risk | Conflicting classifications of pathogenicity | ATXN2-related disorder, ATXN2-related disorder |
| RS746918429 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS778119853 | Health Risk | Conflicting classifications of pathogenicity | GM3 synthase deficiency, GM3 synthase deficiency |
| RS948625674 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS975981325 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, ATXN2-related disorder, Inborn genetic diseases |
| RS774827848 | Health Risk | Likely pathogenic, low penetrance | Tip-toe gait, Tip-toe gait |
| RS193922927 | Health Risk | Pathogenic | Amyotrophic lateral sclerosis, Spinocerebellar ataxia type 2, Spinocerebellar ataxia type 2 |
| RS1885090126 | Health Risk | Pathogenic; risk factor | Spinocerebellar ataxia type 2, Parkinson disease, late-onset |